Trade Summary

1 month ago, Foresite Labs, LLC, serving as 10% owner at Alumis Inc. (ALMS), purchased 72,212 shares at $7.38 per share, for a total transaction value of $532,925.00. Following this transaction, Foresite Labs, LLC now holds 15,778,040 shares of ALMS.

The trade was executed on Friday, November 21, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, November 25, 2025, 4 days after the trade was made.

Alumis Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.